TLDR Planet Labs reported Q4 fiscal 2026 sales of $86.8M, beating the $78M Wall Street estimate Adjusted EBITDA came in at $2.3M, vs an expected loss of ~$6M FY2027TLDR Planet Labs reported Q4 fiscal 2026 sales of $86.8M, beating the $78M Wall Street estimate Adjusted EBITDA came in at $2.3M, vs an expected loss of ~$6M FY2027

Planet Labs (PL) Stock Soars 22% After-Hours on Earnings Beat

2026/03/20 18:41
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Planet Labs reported Q4 fiscal 2026 sales of $86.8M, beating the $78M Wall Street estimate
  • Adjusted EBITDA came in at $2.3M, vs an expected loss of ~$6M
  • FY2027 sales guidance of $415M–$440M crushed analyst models of $380M
  • Stock jumped 22% after-hours to $32.97, after gaining 8.7% in regular trading
  • PL is now up 524% over the past 12 months

Planet Labs PBC posted a strong quarterly beat Thursday, sending the stock sharply higher after the closing bell.

The Earth imaging company reported Q4 fiscal 2026 sales of $86.8 million. Wall Street had been expecting $78 million, according to FactSet.

Adjusted EBITDA came in at $2.3 million. Analysts had modeled a loss of around $6 million. That’s a clean beat on both lines.

Roughly 60% of fiscal 2026 sales came from defense entities. Nearly 25% came from other government customers, with the rest from commercial clients.


PL Stock Card
Planet Labs PBC, PL

CEO Will Marshall called it a “transformational year.” Q4 revenue grew 41% year-over-year, and the company ended the year with $900 million in backlog — up 79% year-over-year.

The stock had already climbed 8.7% during regular trading Thursday. The S&P 500 fell 0.3% and the Dow dropped 0.4% on the same day.

After-hours, PL jumped another 22%, trading at $32.97. That brought the 12-month gain to over 524%.

Before the print, options markets were already flagging something. Call contracts were heavily outpacing puts, with traders clearly leaning bullish heading into the number.

That positioning paid off. The results gave those bets a foundation.

FY2027 Guidance Steals the Show

For fiscal year 2027, Planet Labs is guiding for sales of $415 million to $440 million. Analysts had modeled $380 million. That’s a meaningful gap.

The EBITDA guidance for FY2027 is around $5 million — below the $16 million Wall Street had projected. But investors didn’t seem to care much.

Sales momentum is what the market is tracking here, and the guidance delivered.

A year ago, Wall Street expected FY2027 sales of roughly $330 million. That estimate is now heading toward $430 million.

What’s Driving the Business

Planet cited several milestones in the release. The company launched 40 satellites during the fiscal year and signed an R&D partnership with Google to explore data centers in space.

It also flagged a new satellite services contract with Sweden as part of its recent momentum.

Year-to-date through Thursday’s close, PL was up 25.81% before the after-hours move.

Average daily trading volume sits at around 11.5 million. Technical indicators were already showing a buy signal heading into earnings.

The company’s market cap stood at $8.4 billion before the post-market surge.

At $32.97 after-hours, the stock was reflecting a market that liked what it heard — particularly on the revenue line.

The post Planet Labs (PL) Stock Soars 22% After-Hours on Earnings Beat appeared first on CoinCentral.

Market Opportunity
Audiera Logo
Audiera Price(BEAT)
$0.33888
$0.33888$0.33888
-3.92%
USD
Audiera (BEAT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!